The Medtech Digital Imperative

article image

Medtech’s growing engagement with digital health companies offers the potential of earlier intervention on a patient’s behalf, and also the promise of diversified revenue streams. By Lisa Suennen, Manatt, Phelps & Phillips, and Chandana Fitzgerald, MD, HealthXL.

Medical device companies, with rare exception, are just beginning to enter into meaningful collaborations with digital health businesses, while pharmaceutical companies have been working in the digital sandbox for several years. Most medical device companies are just realizing that these partnerships can help them gain insight not only into the effectiveness of their devices and how best to improve them in future iterations, but also how their use can lead to a better understanding of a patient’s overall health beyond acute care engagement. This can potentially lead to earlier and different interventions as well as diversified revenue streams, particularly as organizations track patients and engage with them around device efficacy and long-term recovery and rehabilitation.


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: